Stock Events

Stock Events

Transmedics Group 

€79.02
2237
+€17.74+28.95%Friday 20:46

Statistics

Day High
79.02
Day Low
67.44
52W High
129.25
52W Low
51.32
Volume
4
Avg. Volume
-
Mkt Cap
2.74B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Nov 5Expected
Q1 2026
Q2 2026
Next
0.26
0.34
0.43
0.51
Expected EPS
0.26492697152
Actual EPS
N/A

Financials

31.17%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
525.73MRevenue
163.89MNet Income

Analyst Ratings

$79.29Average Price Target
The highest estimate is ⁦91.06⁩.
From 6 ratings within the last 6 months. This is not an investment recommendation.
Buy
67%
Hold
33%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TMDX.STU. It's not an investment recommendation.
NVIDIA
899
NVDA
Microsoft
707
MSFT
Amazon
631
AMZN
Realty Income
569
O

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap123.49B
Medtronic offers a range of medical devices and technologies that can compete with TransMedics' organ transplantation solutions.
Abbott Laboratories
ABT
Mkt Cap183.77B
Abbott Laboratories provides a broad portfolio of medical devices, including those for cardiovascular and neuromodulation, which can be seen as indirect competitors to TransMedics' offerings.
Boston Scientific
BSX
Mkt Cap60.84B
Boston Scientific Corporation competes in the medical devices sector, offering products that could be used in cardiovascular procedures, potentially competing with TransMedics' organ preservation technologies.
Stryker
SYK
Mkt Cap111.95B
Stryker Corporation specializes in medical technologies, including surgical equipment and neurotechnology products, which could be used in procedures that compete with TransMedics' transplantation solutions.
Edwards Lifesciences
EW
Mkt Cap53.03B
Edwards Lifesciences Corporation focuses on patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring, which could indirectly compete with TransMedics' technologies.
Zimmer Biomet
ZBH
Mkt Cap18.03B
Zimmer Biomet Holdings, Inc. offers musculoskeletal healthcare solutions, which could be seen as competing in the broader medical devices market against TransMedics' organ preservation and transplantation technologies.
Intuitive Surgical
ISRG
Mkt Cap152.62B
Intuitive Surgical, Inc. develops, manufactures, and markets robotic products for minimally invasive surgery, which could compete with TransMedics in the surgical and transplantation market.
Baxter International
BAX
Mkt Cap11.9B
Baxter International Inc. provides a portfolio of healthcare products, including renal and hospital products, which could compete with TransMedics' organ preservation solutions.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson operates in the healthcare field with a broad range of products. Its medical devices segment could indirectly compete with TransMedics in various areas, including surgical technologies.

About

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Show More
CEO
Waleed H. Hassanein
Employees
898
Country
United States
ISIN
US89377M1099
WKN
000A2PH5P

Listings

MX
MX
TMDX.MX
F
DE
8T8.F
XETRA
DE
8T8.XETRA
MI
IT
1TMDX.MI

0 Comments

Share your thoughts

FAQs

What is Transmedics Group stock price today?▼
The current price of TMDX.STU is €79.02 EUR — it has increased by +28.95% in the past 24 hours. Watch Transmedics Group stock price performance more closely on the chart.
What is Transmedics Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Transmedics Group stocks are traded under the ticker TMDX.STU.
What is Transmedics Group market cap?▼
Today Transmedics Group has the market capitalization of 2.74B
When is the next Transmedics Group earnings date?▼
Transmedics Group is going to release the next earnings report on March 2, 2027.
What is Transmedics Group revenue for the last year?▼
Transmedics Group revenue for the last year amounts to 525.73M EUR.
What is Transmedics Group net income for the last year?▼
TMDX.STU net income for the last year is 163.89M EUR.
How many employees does Transmedics Group have?▼
As of November 8, 2026, the company has 898 employees.
In which sector is Transmedics Group located?▼
Transmedics Group operates in the Health & Wellness sector.
When did Transmedics Group complete a stock split?▼
Transmedics Group has not had any recent stock splits.
Where is Transmedics Group headquartered?▼
Transmedics Group is headquartered in ANDOVER, United States.